OR WAIT null SECS
November 19, 2013
New CDMO to be formed from the combination of DSM Pharmaceutical Products and Patheon in a $2.6-billion transaction.
November 11, 2013
Grifols expands and diversifies portfolio with acquisition of diagnostic business.
November 07, 2013
Biotechnology Industry Organization President James Greenwood writes senators in support of Start-up Jobs and Innovation Act.
November 06, 2013
A roundup of developments in global health and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.
October 02, 2013
Through its educational and networking opportunities, the American Association of Pharmaceutical Scientists plays an important role in partnering throughout the drug- development and commercialization process.
September 11, 2013
New partnership aims to eliminate months from the typical transition time required to move chemistry from the laboratory into commercial applications.
September 04, 2013
September 02, 2013
There has been a notable shift in interest for life-science companies over recent months from institutional investors investing through the public markets, but any plans to release further capital will rely on first-rate R&D.
Pharma eyes biologics production in Brazil as the government begins to recognize the potential of these drugs.
August 01, 2013
Orphan drugs for rare diseases are a major area of investment for pharmaceutical companies, but are they becoming too expensive for Europe to afford them?